Liquid chromatography-high resolution-tandem mass spectrometry using Orbitrap technology for comprehensive screening to detect drugs and their metabolites in blood plasma
Authors:
- 1 May 2017
- journal article
- Published by Elsevier in Analytica Chimica Acta
- Vol. 965, 83-95
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobioticsCritical Care, 2012
- Fragmentation of toxicologically relevant drugs in negative‐ion liquid chromatography–tandem mass spectrometryMass Spectrometry Reviews, 2012
- Rapid Screening for 67 Drugs and Metabolites in Serum or Plasma by Accurate-Mass LC-TOF-MSJournal of Analytical Toxicology, 2012
- Online extraction toxicological MS(n) screening system for serum and heparinized plasma and comparison of screening results between plasma and urine in the context of clinical dataJournal of Chromatography B, 2012
- Fragmentation of toxicologically relevant drugs in positive‐ion liquid chromatography–tandem mass spectrometryMass Spectrometry Reviews, 2011
- Perspectives of Liquid Chromatography Coupled to Low- and High-Resolution Mass Spectrometry for Screening, Identification, and Quantification of Drugs in Clinical and Forensic ToxicologyTherapeutic Drug Monitoring, 2010
- A BIOAVAILABILITY/BIOEQUIVALENCE AND PHARMACOKINETIC STUDY OF TWO ORAL DOSES OF TORASEMIDE (5 AND 10 mg): PROLONGED‐RELEASE VERSUS THE CONVENTIONAL FORMULATIONClinical and Experimental Pharmacology and Physiology, 2009
- Validation of new methodsForensic Science International, 2007
- Dynamic range of mass accuracy in LTQ orbitrap hybrid mass spectrometerJournal of the American Society for Mass Spectrometry, 2006
- Creation and comparison of MS/MS spectral libraries using quadrupole ion trap and triple‐quadrupole mass spectrometersRapid Communications in Mass Spectrometry, 2004